Clinical Impact and Utility of Digital Health Solutions in Participants Receiving Systemic Treatment in Clinical Practice

NCT05694013 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

49

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated by sponsor.

Conditions

Cancer

Interventions

DEVICE: Roche DPM Module
DRUG: Atezolizumab SC
OTHER: Local SOC support

Sponsor

Hoffmann-La Roche